Acute hyperglycaemic crisis after vaccination against COVID-19: A case series

Diabet Med. 2021 Nov;38(11):e14631. doi: 10.1111/dme.14631. Epub 2021 Jul 11.

Authors

Amy E Edwards¹, Ramu Vathenen¹, Sian M Henson², Sarah Finer^{1

3}, Kirun Gunganah¹

Affiliations

¹ Department of Diabetes and Endocrinology, Newham University Hospital, Barts Health NHS Trust, London, UK.
² Centre for Translational Medicine and Therapeutics, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
³ Institute for Population Health Sciences, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

No abstract available

Keywords: clinical diabetes; diabetes; in-patient diabetes; ketoacidosis; metabolic syndrome.

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Acute Disease
Aged
Blood Glucose / metabolism
C-Peptide / metabolism
COVID-19 / prevention & control*
COVID-19 Vaccines / therapeutic use*
ChAdOx1 nCoV-19
Comorbidity
Emergencies
Humans
Hyperglycemia / diagnosis*
Hyperglycemia / epidemiology
Hyperglycemia / metabolism
Hypertension / epidemiology
Male
Metabolic Syndrome / epidemiology
Middle Aged
Prediabetic State / epidemiology
SARS-CoV-2

Substances

Blood Glucose
C-Peptide
COVID-19 Vaccines
ChAdOx1 nCoV-19

Grants and funding

DUK_/Diabetes UK/United Kingdom